Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer.

Among 229 cases in which the tumor had only one single intermediate-risk factor, LVSI alone had the lowest disease-free survival compared to other factors although it did not reach statistical significance (5-year rate, 87.8% for LVSI alone, 94.8% for deep stromal invasion alone, and 100% for large tumor alone, P = 0.11).

also in 111,027 other papers